| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Base editing screens map mutations affecting interferon-γ signaling in cancer
|
Coelho, Matthew A.
|
|
|
41 |
2 |
p. 288-303.e6
|
artikel
|
| 2 |
CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance
|
Nilsson, Monique B.
|
|
|
41 |
2 |
p. 340-355.e6
|
artikel
|
| 3 |
Firing up neutrophil anti-tumor immunity with cocktails
|
Li, Meiyi
|
|
|
41 |
2 |
p. 227-229
|
artikel
|
| 4 |
Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer
|
Martinez-Ordoñez, Anxo
|
|
|
41 |
2 |
p. 252-271.e9
|
artikel
|
| 5 |
IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment
|
Leca, Julie
|
|
|
41 |
2 |
p. 323-339.e10
|
artikel
|
| 6 |
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
|
Liu, Xiaowei
|
|
|
41 |
2 |
p. 272-287.e9
|
artikel
|
| 7 |
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
|
Li, Gaopeng
|
|
|
41 |
2 |
p. 304-322.e7
|
artikel
|
| 8 |
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors
|
Kilian, Michael
|
|
|
41 |
2 |
p. 235-251.e9
|
artikel
|
| 9 |
Neutrophil-activating therapy for the treatment of cancer
|
Linde, Ian L.
|
|
|
41 |
2 |
p. 356-372.e10
|
artikel
|
| 10 |
NKG2A blocks the anti-metastatic functions of natural killer cells
|
Carrette, Florent
|
|
|
41 |
2 |
p. 232-234
|
artikel
|
| 11 |
Paradoxical cancer cell stimulation by IFNγ drives tumor hyperprogression upon checkpoint blockade immunotherapy
|
Champiat, Stephane
|
|
|
41 |
2 |
p. 229-231
|
artikel
|
Tijdschrift beschrijving